BRCA1 and ovarian cancer: As another example, a recent report describing an ovarian cancer patient carrying a pathogenic missense mutation co-occurring in trans with a truncating mutation in BRCA1[7] indicates inheritance of two pathogenic BRCA1 mutations may not be lethal as first assumed [8], and that the likelihood ratio developed for co-occurrence of BRCA1 variants should be amended to reflect this.